4//SEC Filing
ORAGENICS INC 4
Accession 0000899243-16-013529
$OGENCIK 0001174940operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:36 PM ET
Size
20.6 KB
Accession
0000899243-16-013529
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI FAMILY LP
10% Owner
Transactions
- Award
Common Stock
2016-02-16+40,000→ 1,592,523 total - Award
Common Stock
2016-02-16+40,000→ 1,007,878 total - Award
Non-Employee Director Option (Right to Buy)
2016-02-16+80,000→ 80,000 totalExercise: $0.84From: 2017-02-16Exp: 2026-02-16→ Common Stock (80,000 underlying) - Award
Non-Employee Director Option (Right to Buy)
2016-02-16+80,000→ 80,000 totalExercise: $0.84From: 2017-02-16Exp: 2026-02-16→ Common Stock (80,000 underlying)
Holdings
- 7,049,742
Common Stock
- 919,666
Common Stock
- 28,000(indirect: By Koski Management, Inc.)
Common Stock
- 530,851(indirect: By Trust)
Common Stock
Footnotes (9)
- [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Christine L. Koski, a director of the Company.
- [F4]Shares owned directly by Robert C. Koski, a director of the Company.
- [F5]Shares owned directly by Thomas L. Koski.
- [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F7]Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
- [F8]Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2016.
- [F9]Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest equally over two years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 16, 2016.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001174940
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:36 PM ET
- Size
- 20.6 KB